(Boston Children's Hospital) Their research indicates that an already-FDA-approved drug used by cystic fibrosis patients could shield our organs from fibrosis during acute events, like lung infection or heart attack. And looking to the future, they envision that the development of a once-daily pill, capable of inhibiting PAD4, could one day be used as a preventative measure.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2kjigqj
No comments:
Post a Comment